Archive for the ‘News’ Category

Happy Holidays from Comprendia & SDBN: Vote for Donations to #SciFund

Read more

WHITECOAT Strategies and Comprendia Sign Strategic Partnership Agreement to Better Target Key Opinion Leaders, Patients, and Advocates

We’re very pleased to announce a strategic partnership with WHITECOAT Strategies, a Washington, DC-based public relations firm specializing in the use of new media and online video for clients with innovative science, are announcing their recently formed strategic partnership. The alliance will bring integrated video, social media, and strategic PR to life science companies for the first time, allowing them to communicate important scientific concepts more effectively. Please see the full release for more information, and we’d love to hear what you think!

Read more

2 Days, 2 Knights: Sir Philip Cohen Speaks About the Ubiquitin Proteasome System Today

Sir Elton John gave an inspiring and eye-opening keynote speech yesterday about the success and shortcomings of HIV/AIDS research, and I know many of us are still thinking about how we can further the science and make the necessary improvements in education to make a difference. Today, BIO is featuring Sir Philip Cohen, another Knight of the British Empire, often seen as the ‘father’ of kinase biology/phosphorylation research, and one of the most cited scientists in Europe. Sir Cohen, Director of the MRC Protein Phosphorylation Unit, University of Dundee, and Director of the Scottish Institute for Cell Signaling, is speaking in a Breakout Session this morning titled ‘Where to Find the Drugs: The Ubiquitin Component Systems, Are They the Next Generation Kinases?’ He is cited as saying “I am very confident that the (Ubiquitin Proteasome System) market has the potential to become even bigger than Kinases.” The speaker lineup at this 10:00 a.m. session is impressive, including Dr. Frank Mercurio, CSO, BioTheryX, Dr. Mark Manfredi, Director of Cancer Pharmacology, Takeda/Millenium, Prof. Mike Tyers, CH Waddington Professor of Systems Biology at Univ. Edinburgh, Dr. Giovanni Ferrara, ITI Life Sciences Advisory Board, and Dr. Sheridan Snyder, Founder, BioCatalyst International. This session was […]

Read more